Mangalam Drugs and Organics Ltd
BSE:532637

Watchlist Manager
Mangalam Drugs and Organics Ltd Logo
Mangalam Drugs and Organics Ltd
BSE:532637
Watchlist
Price: 40.2 INR -4.99%
Market Cap: ₹636.3m

Operating Margin

-7.1%
Current
Declining
by 9%
vs 3-y average of 1.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-7.1%
=
Operating Income
₹-168.6m
/
Revenue
₹2.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-7.1%
=
Operating Income
₹-168.6m
/
Revenue
₹2.4B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Mangalam Drugs and Organics Ltd
NSE:MANGALAM
634.7m INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219.1B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

Lower than 86% of companies in India
Percentile
14th
Based on 5 437 companies
14th percentile
-7.1%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Mangalam Drugs and Organics Ltd
Glance View

Market Cap
636.3m INR
Industry
Pharmaceuticals

Mangalam Drugs & Organics Ltd. engages in the manufacture of drugs, medicines and allied products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-05-26. The firm handles marketing in both domestic and export markets. The firm is also engaged in the Fight Malaria program for the supply of anti-malarial APIs worldwide. Its API products include Acyclovir, Amodiaquine HCI, Artemether, Artesunate, Atazanavir Sulfate, Atorvastatin Calcium, Bisoprolol Fumarate and Furosemide. Its intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine, 2-Dibutylamino-1-Ethanol (DBA), 4,7- Dichloroquinoline, Ortho Phenoxy Methane Sulfonanilide, Tenofovir Alafenamide Base and Tenofovir Disoproxil Base. The company also offers specialty chemicals, such a L (+)-Menthol, 2,3 Dihydrophthalazine-1,4-dione, 4-Cynoethyl-2- Methyl Phenol. The firm offers its products to Italy, Russia, China, Turkey, Nigeria, Uganda, Kenya and Pakistan. The company has two multi-product manufacturing facilities located at Vapi, district Valsad, Gujarat.

MANGALAM Intrinsic Value
129.51 INR
Undervaluation 69%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-7.1%
=
Operating Income
₹-168.6m
/
Revenue
₹2.4B
What is Mangalam Drugs and Organics Ltd's current Operating Margin?

The current Operating Margin for Mangalam Drugs and Organics Ltd is -7.1%, which is below its 3-year median of 1.9%.

How has Operating Margin changed over time?

Over the last 3 years, Mangalam Drugs and Organics Ltd’s Operating Margin has decreased from 10% to -7.1%. During this period, it reached a low of -7.1% on Jan 31, 2026 and a high of 10% on Dec 1, 2022.

Back to Top